Cobas p 512 Pre-Analytical System, records 10287411043 and 10287410844, hazard class I, various series: 4700920; 4701020; 4701430; 4706631; 4706731; 4706831; 4706931; 4707031; 4707131; 4707231; 4707331; 4707431; 4707631; 4707831; 4708131; 4709431; 4709531; 4709631; 4709731; 4709831; 4709931; 4,710,231; 4,710,331; 4,714,441; 4,717,943; 4,719,644; 4,725,245; 4,725,345; 4,762,545; 4,727,745; 4,728,145; 4,728,245; 4,728,545; 4,730,345; 4,730,645; 4,732,745; 4,733,045; 4733245; 4,733,645; 4,733,745; 4,733,845; 4,734045; 4,735,345. 의 안전성 경고

Agência Nacional de Vigilância Sanitária (ANVISA)에 따르면, 해당 안전성 경고 는 Brazil 에서 Roche Diagnóstica Brasil Ltda.; Roche Diagnostics GmBH 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

안전성 경고는 의료기기 제품과 관련된 중요한 정보와 권고사항을 담고 있습니다. 물론 안전성 경고가 배포되었다고 해서 해당 제품이 무조건 안전하지 않은 제품이라는 것은 아닙니다. 보건의료업계 종사자와 의료기기 사용자들에게 배포되는 안전성 경고에는 회수(recall)도 포함될 수 있습니다. 제조사가 안전성 경고를 작성하기도 하지만, 보건당국에서 작성하는 경우도 있습니다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Safety alert
  • 사례 ID
    1832
  • 날짜
    2016-03-04
  • 사례 국가
  • 사례 출처
    ANVISA
  • 사례 출처 URL
  • 비고 / 경고
    Brazilian data is current through June 2018. All of the data comes from Anvisa, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Brazil.
  • 데이터 추가 비고
    Actions to be taken by the client / user: It was recommended to consider that: The implementation of the software correction is mandatory for the affected systems and will be installed by a Roche Diagnostica Brasil Representative. Until the software fix is ​​implemented, it was recommended that the client / operator monitor the system for the missing tube error 140. If the described situation occurs, all components in contact with the spill must undergo an extra cleaning, as described in the operator's manual. #### Update of the field action: UPDATED ON 10/27/2017, the company presented the report of completion of the field action, with sending of necessary evidences and corrective actions.
  • 원인
    Roche diagnostics gmbh, the legal manufacturer of the product involved in this notification, after a complaint reported abroad, identified the need to update and correct the software of the cobas p 512 pre-analytical system. such modification is necessary because of the incorrect insertion of (rtt), generating risk of contamination of the system and other samples, in addition to loss of material for analysis. so far, this problem has occurred in only three systems of about 400 systems installed in the world. in brazil, no similar complaint has been reported so far.
  • 조치
    Action code SBN_CPS_2016_01. Send letter elaborated on 02/26/2016 of communication to affected clients //// Implementation of software correction for the equipment. If you have any questions regarding this action call 0800-7720295

Manufacturer